CIK 0001795091 · <br>Emerging growth company
OS Therapies Inc
Sign in to watch- Ticker
- OSTX
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 825118368
- Phone
- 410-297-7793
- Business address
- 15825 SHADY GROVE ROAD, SUITE 135, ROCKVILLE, MD, 20850
- DEFA14A Proxy Proxy Materials
- 8-K Event Other events
- 8-K Event Results of operations
- 10-K Report Annual Report
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- UPLOAD Other SEC-generated Letter
- 4 Other acquisition President and CEO acquired 225,000 shares (other)
- 4 Other disposition 10% owner disposed of 225,000 shares (other)
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- DEF 14A Proxy Proxy Statement
- 3/A Insider 3/A
- 4 Open-market sale 10% owner sold 100,000 shares at $2.84 ($284,300)
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- EFFECT Other Notice of Effectiveness
Page 7 of 13 · 247 filings